Abstract: Method for determining at least one membrane property of an analyte sensor having at least two measurement electrodes. At least one of the measurement electrodes comprises at least one membrane element having at least one membrane property. The method includes: a) generating at least one fast-transient voltage signal and applying the fast-transient voltage signal to the measurement electrodes at an application time t0; b) measuring a first response signal U1 at a first time t1 and a second response signal U2 at a second time t2 with t0?t1?t2, wherein the application time t0 precedes the first time t1 and the second time t2; c) determining a response signal U0 at the application time t0 by evaluating the first response signal U1 and the second response signal U2; d) determining the at least one membrane property by evaluating the response signal U0 at the application time t0.

Abstract: A method for detecting a failure of at least one component of a continuous analyte monitoring system is disclosed. The continuous analyte monitoring system has a failure detection resistor and an analyte sensor having at least two measurement electrodes. A constant voltage is applied between the two measurement electrodes and a first response signal is measured. A failure detection signal that is distinguishable from the constant voltage and/or from the first response signal in frequency and/or in height is applied to the continuous monitoring system, and a second response signal to the failure detection signal is measured using the failure detection resistor. Information is determined depending on at least one actual property of the component by evaluating the first response signal and the second response signal. A failure is detected if the information deviates from an expected value by more than a predetermined tolerance.

Abstract: A method for storing measurement data detected by a sensor and indicative of an analyte in a body fluid sample using a system having a processor and a memory. First and second measurement data indicative of first and second measurement values measured by a sensor, respectively, are provided. A relative measurement value is determined by the processor and is indicative of a value difference between the first and second measurement values. The first measurement value is stored in a first storage area having a first storage size in the memory. The relative measurement value is stored in a second storage area having a second storage size in the memory that is smaller than the first storage size. An indicator is also stored in the memory and is assigned to the relative measurement storage data in the memory and is indicative of a characteristic of the relative measurement storage data.

Abstract: A method for determining a membrane property of an analyte sensor that has at least two measurement electrodes and at least one of the measurement electrodes has a membrane having the membrane property. The method includes generating a fast-transient voltage signal and applying the fast-transient voltage signal to the measurement electrodes. A response signal is measured, and the membrane property is determined by evaluating the response signal.

Abstract: Disclosed is a flow detector (1) for releasable coupling with a flow channel (20) in a channel coupling area and detecting a flow of liquid drug in the flow channel (20), the flow detector including: an upstream thermoelectric element (10a) and a downstream thermoelectric element (10b), wherein the upstream thermoelectric element (10a) and the downstream thermoelectric element (10b) are arranged spaced apart from each other and movable independent from each other; an upstream biasing element (15a) and a downstream biasing element (15b), wherein the upstream biasing element (15a) acts on the upstream thermoelectric element (10a), thereby biasing the upstream thermoelectric element (10a) towards the channel coupling area, and the downstream biasing element (15b) acts on the downstream thermoelectric element (10b), thereby biasing the downstream thermoelectric element (10b) towards the channel coupling area independently from the upstream biasing element (15a).

Abstract: Disclosed is a supervision device (9) for supervising liquid drug flow in a flow channel (20). The supervision device (9) includes a flow detector (1), arranged for operatively coupling with the flow channel (20) and generating a flow detector signal in dependence of a flow in the flow channel (20) at a flow detection location. The supervision device (9) further includes a gas detector (8), arranged for operatively coupling with the flow channel (20) and generating a gas detector signal in dependence of whether liquid drug or gas is present in the flow channel (20) at a gas detection location at a distance upstream from the flow detection location.

Abstract: A holder for a medical device has a transcutaneously insertable portion and at least one housing. The holder has at least one mounting device that has a first side and an opposing second side. The mounting device also has a hole reaching from the first side to the second side. The mounting device is configured for being connected to the housing of the medical device. The holder also has two straps that are respectively attached to the mounting device and are fixedly connectable to each other.

Abstract: An analyte measurement kit includes a sensor assembly having a transcutaneous sensor and a controller. The controller includes a battery that powers the sensor assembly and includes a magnetic sensor that generates an electrical activation signal in dependence of a magnetic field. The controller switches from a pre-operative state into an operative state upon generation of the activation signal. The sensor assembly releasably couples to an inserter. The inserter executes an insertion routine that advances the sensor assembly from a retracted position in which the transcutaneous sensor stands back behind a skin contact surface of the inserter into an advanced position in which the transcutaneous sensor projects beyond the skin contact surface, and subsequently decouples the inserter from the sensor assembly. The inserter includes an activation magnet. Executing the insertion routine changes the magnetic coupling between the activation magnet and the sensor assembly and thereby generates the activation signal.

Abstract: An implantable medical device has an implantable power supply and an implantable medical unit. The implantable supply powers the device and it includes a hermetically sealed supply housing, a battery, and a supply power coupler that powers the implantable medical unit from the battery via a wireless coupling. The implantable medical device also has a hermetically sealed medical unit housing, and it includes a functional medical module including a continuous glucose meter module. In use, the implantable medical unit is releasably mechanically coupled to the implantable supply and a wireless coupling of a medical unit power coupler with a supply power coupler is made, thereby powering the medical unit from the battery of the implantable supply.

Abstract: The application relates to a method for producing a sterilized subcutaneous access device, the method comprising: producing a device carrier unit, comprising providing a carrier, producing a subcutaneous access part on the carrier, the subcutaneous access part being provided with at least one of a sensor device for detecting an analyte present in a bodily fluid and an infusion device for infusion of a substance, and producing an electronic assembly on the carrier, the producing comprising printing a battery on a carrier material, and sterilizing the device carrier unit by radiation sterilization, the sterilizing comprising exposing the printed battery to the radiation applied for sterilization. Furthermore, the application relates to a sterilized subcutaneous access device.

Abstract: Disclosed is a flow detector (1) for releasable coupling with a flow channel (20) in a channel coupling area and detecting a flow of liquid drug in the flow channel (20), the flow detector including: an upstream thermoelectric element (10a) and a downstream thermoelectric element (10b), wherein the upstream thermoelectric element (10a) and the downstream thermoelectric element (10b) are arranged spaced apart from each other and movable independent from each other; an upstream biasing element (15a) and a downstream biasing element (15b), wherein the upstream biasing elements (15a) acts on the upstream thermoelectric element (10a), thereby biasing the upstream thermoelectric element (10a) towards the channel coupling area, and the downstream biasing element (15b) acts on the downstream thermoelectric element (10b), thereby biasing the downstream thermoelectric element (10b) towards the channel coupling area independently from the upstream biasing element (15a).

Abstract: Disclosed is a supervision device (9) for supervising liquid drug flow in a flow channel (20). The supervision device (9) includes a flow detector (1), arranged for operatively coupling with the flow channel (20) and generating a flow detector signal in dependence of a flow in the flow channel (20) at a flow detection location. The supervision device (9) further includes a gas detector (8), arranged for operatively coupling with the flow channel (20) and generating a gas detector signal in dependence of whether liquid drug or gas is present in the flow channel (20) at a gas detection location at a distance upstream from the flow detection location.

Abstract: Methods, analytical devices and analytical systems are provided for determining at least one analyte concentration in a body fluid sample. The methods, which may be incorporated into the devices and systems, can include the following steps: applying a body fluid to a test carrier; illuminating the test carrier by at least one light source, where the at least one light source is modulated by using at least two modulation frequencies; receiving light remitted by the test carrier by using at least one detector; determining an analyte concentration by evaluating at least one detector signal generated by the detector, where the detector signal is demodulated with the at least two modulation frequencies to generate at least two demodulated detector signals, each demodulated signal corresponding to one of the modulation frequencies; and detecting a fault by comparing the at least two demodulated detector signals.

Abstract: Disclosed is an analyte measuring patch for invasive measuring a concentration of an analyte, in particular glucose. The analyte measuring patch includes a sensor with a working electrode (101), a counter electrode (103) and a reference electrode 102). The patch further includes an electronics unit with a microcontroller (1200) and a current measurement unit. The microcontroller (1200) includes a control output (DAC), a first analogue input (ADC-1) and a second analogue input (ADC-2). The control output (DAC) is operatively coupled with a control electrode, the control electrode being either of the working electrode or (101) or the counter electrode (103). The first analogue input (ADC-2) is operatively coupled with a measurement electrode via the current measurement unit, the measurement electrode being either of the working electrode (101) or the counter electrode (103). The second analogue input (ADC-1) is operatively coupled with the reference electrode (102).

Abstract: The application relates to a method for producing a sterilized subcutaneous access device, the method comprising: producing a device carrier unit, comprising providing a carrier, producing a subcutaneous access part on the carrier, the subcutaneous access part being provided with at least one of a sensor device for detecting an analyte present in a bodily fluid and an infusion device for infusion of a substance, and producing an electronic assembly on the carrier, the producing comprising printing a battery on a carrier material, and sterilizing the device carrier unit by radiation sterilization, the sterilizing comprising exposing the printed battery to the radiation applied for sterilization. Furthermore, the application relates to a sterilized subcutaneous access device.

Abstract: Methods, analytical devices and analytical systems are provided for determining at least one analyte concentration in a body fluid sample. The methods, which may be incorporated into the devices and systems, can include the following steps: applying a body fluid to a test carrier; illuminating the test carrier by at least one light source, where the at least one light source is modulated by using at least two modulation frequencies; receiving light remitted by the test carrier by using at least one detector; determining an analyte concentration by evaluating at least one detector signal generated by the detector, where the detector signal is demodulated with the at least two modulation frequencies to generate at least two demodulated detector signals, each demodulated signal corresponding to one of the modulation frequencies; and detecting a fault by comparing the at least two demodulated detector signals.

Abstract: A puncturing system includes a carrier tape carrying multiple lancets and having position marks, a housing comprising a conveying facility for positioning the lancets and a housing opening, a puncturing drive for accelerating a lancet positioned in a usage position, a storage medium for storing distance values that depend on distances between the lancets of the carrier tape and position marks allocated to the respective lancets, a sensor for detecting position marks in a detection position through which the position marks proceed upon motion of the carrier tape, and a control unit that controls the conveying facility. To position a lancet in the usage position, the control unit stops the conveying facility upon the carrier tape moving a positioning distance. The length of the positioning distance depends on the distance between the lancet to be positioned and the detected position mark and is determined by the control unit.

Abstract: There is disclosed a method for controlling a photometric measuring unit of a measuring device for a bodily fluid sample, wherein a test field partially wetted by a bodily fluid sample is illuminated and light from a measuring area that covers a portion of the test field of the measuring unit is fed to a detector of the measuring unit, and the measuring area is displaced relative to the test field toward a partial surface wetted by the fluid sample and past the partial surface. The intensity of a detector signal is detected during the displacement, an extreme value in the course of the detector signal is determined, the measuring area is brought back to the position in which an extreme detector signal was previously measured, and the position of the measuring area in which the detector signal is extreme is used for a photometric determination of concentration.

Abstract: A measuring system for determining blood glucose includes a photometric measuring unit with a light source and a detector, and an analytical test element, to which a body fluid sample can be applied, and which can be placed in a beam path between the light source and the detector for optical detection of an analyte. For an improved multi-wavelength measurement, it is proposed that the light source includes a first emitter that can be actuated in a first wavelength range to emit pulsating alternating light and a second emitter that can be excited in a second wavelength range to emit fluorescent light.

Abstract: A measuring system for determining blood glucose includes a photometric measuring unit with a light source and a detector, and an analytical test element, to which a body fluid sample can be applied, and which can be placed in a beam path between the light source and the detector for optical detection of an analyte. For an improved multi-wavelength measurement, it is proposed that the light source includes a first emitter that can be actuated in a first wavelength range to emit pulsating alternating light and a second emitter that can be excited in a second wavelength range to emit fluorescent light.